Pulmonary and systemic nitric oxide metabolites in a baboon model of neonatal chronic lung disease

David A. Munson, Peter H. Grubb, Jay D. Kerecman, Donald C. McCurnin, Bradley A. Yoder, Stanley L. Hazen, Philip W. Shaul, Harry Ischiropoulos

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

We report on developmental changes of pulmonary and systemic nitric oxide (NO) metabolites in a baboon model of chronic lung disease with or without exposure to inhaled NO. The plasma levels of nitrite and nitrate, staining for S-nitrosothiols and 3-nitrotyrosine in the large airways, increased between 125 d and 140d of gestation (term 185 d) in animals developing in utero. The developmental increase in NO-mediated protein modifications was not interrupted by delivery at 125 d of gestation and mechanical ventilation for 14 d, whereas plasma nitrite and nitrate levels increased in this model. Exposure to inhaled NO resulted in a further increase in plasma nitrite and nitrate and an increase in plasma S-nitrosothiol without altering lung NO synthase expression. These data demonstrate a developmental progression in levels of pulmonary NO metabolites that parallel known maturational increases in total NO synthase activity in the lung. Despite known suppression of total pulmonary NO synthase activity in the chronic lung disease model, pulmonary and systemic NO metabolite levels are higher than in the developmental control animals. Thus, a deficiency in NO production and biological function in the premature baboon was not apparent by the detection and quantification of these surrogate markers of NO production.

Original languageEnglish (US)
Pages (from-to)582-588
Number of pages7
JournalAmerican Journal of Respiratory Cell and Molecular Biology
Volume33
Issue number6
DOIs
StatePublished - Dec 2005

Fingerprint

Pulmonary diseases
Papio
Metabolites
Lung Diseases
Nitric Oxide
Chronic Disease
Lung
Nitrites
S-Nitrosothiols
Nitric Oxide Synthase
Nitrates
Plasmas
Animals
Pregnancy
Artificial Respiration
Biomarkers
Staining and Labeling

Keywords

  • 3-nitrotyrosine
  • Baboon
  • Chronic lung disease
  • Nitric oxide
  • Prematurity
  • S-nitrosocysteine
  • S-nitrosothiols

ASJC Scopus subject areas

  • Cell Biology
  • Pulmonary and Respiratory Medicine
  • Molecular Biology

Cite this

Munson, D. A., Grubb, P. H., Kerecman, J. D., McCurnin, D. C., Yoder, B. A., Hazen, S. L., ... Ischiropoulos, H. (2005). Pulmonary and systemic nitric oxide metabolites in a baboon model of neonatal chronic lung disease. American Journal of Respiratory Cell and Molecular Biology, 33(6), 582-588. https://doi.org/10.1165/rcmb.2005-0182OC

Pulmonary and systemic nitric oxide metabolites in a baboon model of neonatal chronic lung disease. / Munson, David A.; Grubb, Peter H.; Kerecman, Jay D.; McCurnin, Donald C.; Yoder, Bradley A.; Hazen, Stanley L.; Shaul, Philip W.; Ischiropoulos, Harry.

In: American Journal of Respiratory Cell and Molecular Biology, Vol. 33, No. 6, 12.2005, p. 582-588.

Research output: Contribution to journalArticle

Munson, David A. ; Grubb, Peter H. ; Kerecman, Jay D. ; McCurnin, Donald C. ; Yoder, Bradley A. ; Hazen, Stanley L. ; Shaul, Philip W. ; Ischiropoulos, Harry. / Pulmonary and systemic nitric oxide metabolites in a baboon model of neonatal chronic lung disease. In: American Journal of Respiratory Cell and Molecular Biology. 2005 ; Vol. 33, No. 6. pp. 582-588.
@article{6e8816f8662841888ed360e2ca0daffe,
title = "Pulmonary and systemic nitric oxide metabolites in a baboon model of neonatal chronic lung disease",
abstract = "We report on developmental changes of pulmonary and systemic nitric oxide (NO) metabolites in a baboon model of chronic lung disease with or without exposure to inhaled NO. The plasma levels of nitrite and nitrate, staining for S-nitrosothiols and 3-nitrotyrosine in the large airways, increased between 125 d and 140d of gestation (term 185 d) in animals developing in utero. The developmental increase in NO-mediated protein modifications was not interrupted by delivery at 125 d of gestation and mechanical ventilation for 14 d, whereas plasma nitrite and nitrate levels increased in this model. Exposure to inhaled NO resulted in a further increase in plasma nitrite and nitrate and an increase in plasma S-nitrosothiol without altering lung NO synthase expression. These data demonstrate a developmental progression in levels of pulmonary NO metabolites that parallel known maturational increases in total NO synthase activity in the lung. Despite known suppression of total pulmonary NO synthase activity in the chronic lung disease model, pulmonary and systemic NO metabolite levels are higher than in the developmental control animals. Thus, a deficiency in NO production and biological function in the premature baboon was not apparent by the detection and quantification of these surrogate markers of NO production.",
keywords = "3-nitrotyrosine, Baboon, Chronic lung disease, Nitric oxide, Prematurity, S-nitrosocysteine, S-nitrosothiols",
author = "Munson, {David A.} and Grubb, {Peter H.} and Kerecman, {Jay D.} and McCurnin, {Donald C.} and Yoder, {Bradley A.} and Hazen, {Stanley L.} and Shaul, {Philip W.} and Harry Ischiropoulos",
year = "2005",
month = "12",
doi = "10.1165/rcmb.2005-0182OC",
language = "English (US)",
volume = "33",
pages = "582--588",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "6",

}

TY - JOUR

T1 - Pulmonary and systemic nitric oxide metabolites in a baboon model of neonatal chronic lung disease

AU - Munson, David A.

AU - Grubb, Peter H.

AU - Kerecman, Jay D.

AU - McCurnin, Donald C.

AU - Yoder, Bradley A.

AU - Hazen, Stanley L.

AU - Shaul, Philip W.

AU - Ischiropoulos, Harry

PY - 2005/12

Y1 - 2005/12

N2 - We report on developmental changes of pulmonary and systemic nitric oxide (NO) metabolites in a baboon model of chronic lung disease with or without exposure to inhaled NO. The plasma levels of nitrite and nitrate, staining for S-nitrosothiols and 3-nitrotyrosine in the large airways, increased between 125 d and 140d of gestation (term 185 d) in animals developing in utero. The developmental increase in NO-mediated protein modifications was not interrupted by delivery at 125 d of gestation and mechanical ventilation for 14 d, whereas plasma nitrite and nitrate levels increased in this model. Exposure to inhaled NO resulted in a further increase in plasma nitrite and nitrate and an increase in plasma S-nitrosothiol without altering lung NO synthase expression. These data demonstrate a developmental progression in levels of pulmonary NO metabolites that parallel known maturational increases in total NO synthase activity in the lung. Despite known suppression of total pulmonary NO synthase activity in the chronic lung disease model, pulmonary and systemic NO metabolite levels are higher than in the developmental control animals. Thus, a deficiency in NO production and biological function in the premature baboon was not apparent by the detection and quantification of these surrogate markers of NO production.

AB - We report on developmental changes of pulmonary and systemic nitric oxide (NO) metabolites in a baboon model of chronic lung disease with or without exposure to inhaled NO. The plasma levels of nitrite and nitrate, staining for S-nitrosothiols and 3-nitrotyrosine in the large airways, increased between 125 d and 140d of gestation (term 185 d) in animals developing in utero. The developmental increase in NO-mediated protein modifications was not interrupted by delivery at 125 d of gestation and mechanical ventilation for 14 d, whereas plasma nitrite and nitrate levels increased in this model. Exposure to inhaled NO resulted in a further increase in plasma nitrite and nitrate and an increase in plasma S-nitrosothiol without altering lung NO synthase expression. These data demonstrate a developmental progression in levels of pulmonary NO metabolites that parallel known maturational increases in total NO synthase activity in the lung. Despite known suppression of total pulmonary NO synthase activity in the chronic lung disease model, pulmonary and systemic NO metabolite levels are higher than in the developmental control animals. Thus, a deficiency in NO production and biological function in the premature baboon was not apparent by the detection and quantification of these surrogate markers of NO production.

KW - 3-nitrotyrosine

KW - Baboon

KW - Chronic lung disease

KW - Nitric oxide

KW - Prematurity

KW - S-nitrosocysteine

KW - S-nitrosothiols

UR - http://www.scopus.com/inward/record.url?scp=28644447579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28644447579&partnerID=8YFLogxK

U2 - 10.1165/rcmb.2005-0182OC

DO - 10.1165/rcmb.2005-0182OC

M3 - Article

VL - 33

SP - 582

EP - 588

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 6

ER -